181 related articles for article (PubMed ID: 37872086)
21. [Hepatocellular carcinoma: diagnosis and multi-modality therapy].
Kubicka S; Rudolph L; Manns MP
Internist (Berl); 1997 Oct; 38(10):954-62. PubMed ID: 9432503
[No Abstract] [Full Text] [Related]
22. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
Llovet JM; Fuster J; Bruix J;
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
[TBL] [Abstract][Full Text] [Related]
23. UCHID consensus for hepatocellular carcinoma.
Mostafa EF; Alaty WHA; Abdelmalek M; Salaheldin M; Zaghlol A; Allam E; Cordie A; Tharwat M; Abdallah M; Esmat G
Arab J Gastroenterol; 2023 Feb; 24(1):73-75. PubMed ID: 36746704
[No Abstract] [Full Text] [Related]
24. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
25. [Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition)].
Bureau of Medical Administration, National Health Commission of the People's Republic of China
Zhonghua Gan Zang Bing Za Zhi; 2022 Apr; 30(4):367-388. PubMed ID: 35545562
[No Abstract] [Full Text] [Related]
26. [Diagnosis and therapy of hepatocellular carcinoma].
Reinwald H
Med Klin (Munich); 1997 Nov; 92(11):663-74. PubMed ID: 9480398
[TBL] [Abstract][Full Text] [Related]
27. [Chinese multidisciplinary expert consensus on combined immunotherapy based on immune checkpoint inhibitors for hepatocellular carcinoma(2021 version)].
; ;
Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):636-647. PubMed ID: 34371534
[TBL] [Abstract][Full Text] [Related]
28. [Current therapeutic strategies for hepatocellular carcinoma].
Geier A; Schadde E; Müllhaupt B
MMW Fortschr Med; 2012 Jul; 154(13):63-7; quiz 68-9. PubMed ID: 22957387
[No Abstract] [Full Text] [Related]
29. Management of fibrolamellar hepatocellular carcinoma.
Chaudhari VA; Khobragade K; Bhandare M; Shrikhande SV
Chin Clin Oncol; 2018 Oct; 7(5):51. PubMed ID: 30395718
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma.
Daoudaki M; Fouzas I
Wien Med Wochenschr; 2014 Nov; 164(21-22):450-5. PubMed ID: 25182146
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.
Malfertheiner P; Verslype C; Kolligs FT; Schütte K; Vandecaveye V; Paprottka PM; Ricke J
Future Oncol; 2014 Nov; 10(15 Suppl):17-27. PubMed ID: 25478762
[No Abstract] [Full Text] [Related]
32. Diagnosis and treatment of hepatocellular carcinoma.
Suarez Y; Sala M; Llovet JM; Bruix J
Acta Gastroenterol Belg; 1999; 62(4):410-4. PubMed ID: 10692771
[TBL] [Abstract][Full Text] [Related]
33. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
34. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.
Shiani A; Narayanan S; Pena L; Friedman M
Cancer Control; 2017; 24(3):1073274817729240. PubMed ID: 28975833
[TBL] [Abstract][Full Text] [Related]
35. Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective.
Hui RW; Mak LY; Cheung TT; Lee VH; Seto WK; Yuen MF
Clin Mol Hepatol; 2023 Apr; 29(2):217-229. PubMed ID: 36577426
[TBL] [Abstract][Full Text] [Related]
36. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
Kudo M; Okanoue T;
Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
[TBL] [Abstract][Full Text] [Related]
37. Mexican consensus on the diagnosis and management of hepatocellular carcinoma.
González Huezo MS; Sánchez Ávila JF; ; ; ; ; ;
Rev Gastroenterol Mex; 2014; 79(4):250-62. PubMed ID: 25487133
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Verslype C; Rosmorduc O; Rougier P;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii41-8. PubMed ID: 22997453
[No Abstract] [Full Text] [Related]
39. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
Zhang DZ; Niu JQ
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular Carcinoma.
Gilles H; Garbutt T; Landrum J
Crit Care Nurs Clin North Am; 2022 Sep; 34(3):289-301. PubMed ID: 36049848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
